🇺🇸 FDA
Pipeline program

BDP Nasal Aerosol

BDP-AR-306

Phase 3 small_molecule completed

Quick answer

BDP Nasal Aerosol for Allergic Rhinitis is a Phase 3 program (small_molecule) at TEVA PHARMACEUTICAL INDUSTRIES LTD with 1 ClinicalTrials.gov record(s).

Program details

Company
TEVA PHARMACEUTICAL INDUSTRIES LTD
Indication
Allergic Rhinitis
Phase
Phase 3
Modality
small_molecule
Status
completed

Clinical trials